[willk]

“Interestingly, through a follow-up survey, we found that none of our 80 SLE patients who took long-term oral HCQ had been confirmed to have SARS-CoV-2 infection or appeared to have related symptoms. In addition, among the 178 patients diagnosed with COVID-19 pneumonia in our hospital, none were receiving HCQ treatment before admission. All predicting the use of HCQ in SARS-CoV-2 infections.”

So why can’t we do a simular study here to see if we can confirm these findings??

[Cathi]

They are beginning trials.

https://whyy.org/articles/possible-treatment-for-covid-19-enters-clinical-trial-at-penn/

https://techcrunch.com/2020/04/02/henry-ford-health-system-to-conduct-first-large-u-s-study-of-hydroxychloroquines-ability-to-prevent-covid-19/